1-9 of 9
Alexander Steinle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3652: Surface expression and shedding of NKG2D ligands by (metastasizing) tumor cells is altered by platelets leading to impaired NK cell immunosurveillance

Stefanie Raab, Korbinian Nepomuk Kropp, Alexander Steinle, Gerd Klein, Hans-Georg Kopp, Helmut R. Salih
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3652.
https://doi.org/10.1158/1538-7445.AM2014-3652
Published: 01 October 2014
View article titled, Abstract 3652: Surface expression and shedding of NKG2D ligands by (metastasizing) tumor cells is altered by platelets leading to impaired NK cell immunosurveillance
Journal Articles

Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D

Anja Heinemann, Fang Zhao, Sonali Pechlivanis, Jürgen Eberle, Alexander Steinle, Sven Diederichs, Dirk Schadendorf, Annette Paschen
Journal: Cancer Research
Cancer Res (2012) 72 (2): 460–471.
https://doi.org/10.1158/0008-5472.CAN-11-1977
Published: 16 January 2012
View article titled, Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
Open the PDF for Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D in another window
Includes: Supplementary data
Journal Articles

Abstract #5078: Modulation of natural killer cell-mediated immunotherapy of hepatoblastoma by histone deacetylase inhibitors

Sorin Armeanu, Matthias Pfeiffer, Guido Seitz, Peter Lang, Rupert Handgretinger, Claudia Mueller, Alexander Steinle, Jörg Fuchs, Steven Warmann
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5078.
Published: 01 May 2009
View article titled, Abstract #5078: Modulation of natural killer cell-mediated immunotherapy of hepatoblastoma by histone deacetylase inhibitors
Journal Articles

Tumor-Associated MICA Is Shed by ADAM Proteases

Inja Waldhauer, Dennis Goehlsdorf, Friederike Gieseke, Toni Weinschenk, Mareike Wittenbrink, Andreas Ludwig, Stefan Stevanovic, Hans-Georg Rammensee, Alexander Steinle
Journal: Cancer Research
Cancer Res (2008) 68 (15): 6368–6376.
https://doi.org/10.1158/0008-5472.CAN-07-6768
Published: 01 August 2008
View article titled, Tumor-Associated MICA Is Shed by ADAM Proteases
Open the PDF for Tumor-Associated MICA Is Shed by ADAM Proteases in another window
Includes: Supplementary data
Journal Articles

Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells

Inja Waldhauer, Alexander Steinle
Journal: Cancer Research
Cancer Res (2006) 66 (5): 2520–2526.
https://doi.org/10.1158/0008-5472.CAN-05-2520
Published: 01 March 2006
View article titled, Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Open the PDF for Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells in another window
Journal Articles

Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate

Sorin Armeanu, Michael Bitzer, Ulrich M. Lauer, Sascha Venturelli, Anita Pathil, Matthias Krusch, Stephan Kaiser, Jürgen Jobst, Irina Smirnow, Annika Wagner, Alexander Steinle, Helmut R. Salih
Journal: Cancer Research
Cancer Res (2005) 65 (14): 6321–6329.
https://doi.org/10.1158/0008-5472.CAN-04-4252
Published: 15 July 2005
View article titled, Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate
Open the PDF for Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate in another window
Journal Articles

Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by Trans -Retinoic Acid

Alessandro Poggi, Claudia Venturino, Silvia Catellani, Marino Clavio, Maurizio Miglino, Marco Gobbi, Alexander Steinle, Paolo Ghia, Stefania Stella, Federico Caligaris-Cappio, Maria Raffaella Zocchi
Journal: Cancer Research
Cancer Res (2004) 64 (24): 9172–9179.
https://doi.org/10.1158/0008-5472.CAN-04-2417
Published: 16 December 2004
View article titled, Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by <em>Trans</em> -Retinoic Acid
Open the PDF for Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by <em>Trans</em> -Retinoic Acid in another window
Journal Articles

RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo

Manuel A. Friese, Jörg Wischhusen, Wolfgang Wick, Markus Weiler, Günter Eisele, Alexander Steinle, Michael Weller
Journal: Cancer Research
Cancer Res (2004) 64 (20): 7596–7603.
https://doi.org/10.1158/0008-5472.CAN-04-1627
Published: 15 October 2004
View article titled, RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity <em>In vivo</em>
Open the PDF for RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity <em>In vivo</em> in another window
Journal Articles

MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas

Manuel A. Friese, Michael Platten, Stefan Z. Lutz, Ulrike Naumann, Steffen Aulwurm, Felix Bischof, Hans-Jörg Bühring, Johannes Dichgans, Hans-Georg Rammensee, Alexander Steinle, Michael Weller
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8996–9006.
Published: 24 December 2003
View article titled, MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas
Open the PDF for MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas in another window